Nucleus Capital (investor - Venture Capital)
See something wrong or missing? Let us know
Offices:Berlin
Nucleus Capital is a new venture capital company founded in Germany by Maximilian A. Bade in 2020.
- in 2024, Nucleus Capital announced 90% commitments for a €40 million fund focused on synthetic biology startups in Germany.
Average round investment:4.48M USD
Average number per year:6.2
Distribution:
2025 (3)2024 (3)2023 (7)2022 (10)2021 (8)
Mostly invests in:
Germany (15)
Manufacturing (21)

See the entire list
Showing 3 of 31 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Nucleus Capital mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Nucleus Capital
Name | Criteria | |
---|---|---|
![]() |
Flash Ventures
100%
|
|
![]() |
Morrow Ventures
100%
|
|
![]() |
Chris Adelsbach
100%
|
|
![]() |
Luca Ascani
100%
|
|
![]() |
Maria Scuri
100%
|
|
![]() |
Blaise Kremer
100%
|
|
![]() |
Serge Chiaramonte
99%
|
|
![]() |
Luke Appleby
99%
|
|
![]() |
Italian Angels for Growth
99%
|
|
![]() |
Verena Pausder
99%
|
|